Quick Answer
Pacira BioSciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $158.55 million for the year ending 2025.
- Pacira BioSciences, Inc. showed a decrease of -42.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Pacira BioSciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Pacira BioSciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,140.3%.
- Historical annual values: Fiscal year 2025: $158.55 million | Fiscal year 2024: $276.77 million | Fiscal year 2023: $153.30 million | Fiscal year 2022: $104.14 million | Fiscal year 2021: $585.58 million | Fiscal year 2020: $99.96 million | Fiscal year 2019: $78.23 million | Fiscal year 2018: $132.53 million | Fiscal year 2017: $54.13 million | Fiscal year 2016: $35.94 million | Fiscal year 2015: $56.98 million | Fiscal year 2014: $37.52 million | Fiscal year 2013: $12.52 million | Fiscal year 2012: $12.52 million | Fiscal year 2011: $46.17 million | Fiscal year 2010: $26.13 million | Fiscal year 2009: $7.08 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: